NovoCure (NVCR) Non-Current Deferred Tax Liability (2018)
NovoCure recorded quarterly Non-Current Deferred Tax Liability of $124000.0 in Q4 2018.
NovoCure's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $124000.0 for Q4 2018.
- In Q4 2018, Non-Current Deferred Tax Liability changed N/A year-over-year to $124000.0; the TTM figure through Dec 2018 stood at $124000.0 (changed N/A YoY), while the FY2018 annual figure was $124000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability came in at $124000.0 for Q4 2018 at NovoCure.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $124000.0 in Q4 2018 to a low of $124000.0 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 124,000.00 |
| Dec 31, 2018 | 124,000.00 |